Novo Nordisk’ chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate ... representative in the GLP-1 agonist market to testify at the hearing. At BIO 2025, vaccines were ...

Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of leadership was required amid fierce glucagon-like peptide 1 receptor ...

Kaia Hubbard is a politics reporter for CBS News Digital, based in Washington, D.C. Novo Nordisk CEO Lars Fruergaard Jørgensen ... the three leading PBMs had agreed to not reduce access to ...

Sept. 24 (UPI) --The CEO of Novo Nordisk is on Capitol Hill Tuesday to testify before a Senate committee about the high costs of its drugs Ozempic and Wegovy. Chairman Sen. Bernie Sanders ...

Jørgensen has agreed to serve as the company’s CEO on an interim basis until his replacement is found. The Danish pharma giant added that Lars Rebien Sørensen, chair of the Novo Nordisk ...

Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish drugmaker on Friday abruptly announced that longtime CEO Lars Fruergaard ...

The Danish drugmaker on Friday abruptly announced that longtime CEO Lars ... of several of Novo Nordisk's other recent tie-ups. For example, Novo Nordisk in March said it had agreed to pay up ...

Novo Nordisk's stock is still up more than 250% since Jørgensen took over as CEO in January 2017. But shares of Eli Lilly have gained about 800% since that same month, when CEO Dave Ricks took ...